target again family ystein proteam one novel strategy develop chemotherapy number disease proteam inhibitor derive pyridylimidazoapyridin metres pharmacology import class compound report first time derive init design screen silicon molecular dock studi explore possible mode action interact found similar interact observe respect epoxy inhibitor ec subset synths valid efficacy wet lab expert character kinen show ki ic value rang µm respect thermodynamic suggest bind hydrophobic entropy driven also inhibit growth clinic differ type gram post neg bacteria mic µml base lipinski rule five propos potent antibacteri prodrug active compound pyridylhydroxyphenylimidazoapyridin 